Innovation in Obesity Therapeutics Summit
Transforming Obesity Treatment Differentiation Beyond Simple Weight Loss: a Unique, MRI-Based Approach
This December 10-12, the West Coast Innovation in Obesity Therapeutics Summit will be taking place in sunny San Diego, California! AMRA is excited to share that we are a 2024 Summit Expertise Partner, helping to make this event a success in conjunction with the Summit and our industry collaborators.
Our CEO, Dr. Olof Dahlqvist Leinhard, will be headlining a seminar centered around the use of novel MRI-based body composition approaches, notably AMRA’s unique fat distribution and muscle volume z-score biomarkers, to transform treatment differentiation methods beyond simple weight loss comparisons in obesity trials.
Dr. Leinhard will take attendees on a journey through the advent of the z-score methodologies via robust AMRA-led studies, as well as their utility in exploring varying effects of the incretin-based therapies on muscle and fat measurements in recent blockbuster trials.
If you’re attending the conference – we want to meet you! Reach out to info@amramedical.com to get in touch with the team ahead of the Summit, or to learn more about how our unique fat and muscle body composition assessments are transforming disease research in obesity and beyond.
Interested to learn more about AMRA’s perspective on weight loss and its impact on obesity?
Olof Dahlqvist Leinhard, PhD
MRI-based Body Composition Reimagined: Building a New Foundation for Treatment Differentiation Beyond Weight Loss
DoubleTree by Hilton San Diego-Mission Valley
Conference Day One:
Dec 11, 09:00 AM
Follow us on social media
Follow AMRA Medical on social media for the latest updates in body composition and precision medicine. Please use your preferred social media platform below:
Latest News
-
AMRA at MDA 2025 – Presents research from one of the largest natural history studies to date, validating our unique, MRI-based biomarkers for use as endpoints in upcoming FSHD trials